Effects of Pimozide Derivatives on pSTAT5 in K562 Cells

Stefania Grimaudo, Maria Meli, Rosaria Maria Pipitone, Daniele Simoni, Antonio Cascio, Riccardo Rondanin, Daniele Simoni, Romeo Romagnoli, Martina Maccesi

Risultato della ricerca: Article

5 Citazioni (Scopus)

Abstract

STAT5 is a transcription factor, a member of the STAT family of signaling proteins. STAT5 is involved in many types of cancer, including chronic myelogenous leukemia (CML), in which this protein is found constitutively activated as a consequence of BCR-ABL expression. The neuroleptic drug pimozide was recently reported to act as an inhibitor of STAT5 phosphorylation and is capable of inducing apoptosis in CML cells in vitro. Our research group has synthesized simple derivatives of pimozide with cytotoxic activity and that are able to decrease the levels of phosphorylated STAT5. In this work we continued the search for novel STAT5 inhibitors, synthesizing compounds in which the benzoimidazolinone ring of pimozide is either maintained or modified, in order to obtain further structure–activity relationship information for this class of STAT5 inhibitors. Two compounds of the series showed potent cytotoxic activity against BCR-ABL-positive and pSTAT5-overexpressing K562 cells and were able to markedly decrease the levels of phosphorylated STAT5.
Lingua originaleEnglish
pagine (da-a)1183-1190
Numero di pagine8
RivistaChemMedChem
Volume12
Stato di pubblicazionePublished - 2017

Fingerprint

Pimozide
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Derivatives
Phosphorylation
Structure-Activity Relationship
Antipsychotic Agents
Proteins
Transcription Factors
Apoptosis
Research
Neoplasms

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Organic Chemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cita questo

Effects of Pimozide Derivatives on pSTAT5 in K562 Cells. / Grimaudo, Stefania; Meli, Maria; Pipitone, Rosaria Maria; Simoni, Daniele; Cascio, Antonio; Rondanin, Riccardo; Simoni, Daniele; Romagnoli, Romeo; Maccesi, Martina.

In: ChemMedChem, Vol. 12, 2017, pag. 1183-1190.

Risultato della ricerca: Article

Grimaudo, S, Meli, M, Pipitone, RM, Simoni, D, Cascio, A, Rondanin, R, Simoni, D, Romagnoli, R & Maccesi, M 2017, 'Effects of Pimozide Derivatives on pSTAT5 in K562 Cells', ChemMedChem, vol. 12, pagg. 1183-1190.
Grimaudo, Stefania ; Meli, Maria ; Pipitone, Rosaria Maria ; Simoni, Daniele ; Cascio, Antonio ; Rondanin, Riccardo ; Simoni, Daniele ; Romagnoli, Romeo ; Maccesi, Martina. / Effects of Pimozide Derivatives on pSTAT5 in K562 Cells. In: ChemMedChem. 2017 ; Vol. 12. pagg. 1183-1190.
@article{806ef8937daa4f1487a7caba91c9890f,
title = "Effects of Pimozide Derivatives on pSTAT5 in K562 Cells",
abstract = "STAT5 is a transcription factor, a member of the STAT family of signaling proteins. STAT5 is involved in many types of cancer, including chronic myelogenous leukemia (CML), in which this protein is found constitutively activated as a consequence of BCR-ABL expression. The neuroleptic drug pimozide was recently reported to act as an inhibitor of STAT5 phosphorylation and is capable of inducing apoptosis in CML cells in vitro. Our research group has synthesized simple derivatives of pimozide with cytotoxic activity and that are able to decrease the levels of phosphorylated STAT5. In this work we continued the search for novel STAT5 inhibitors, synthesizing compounds in which the benzoimidazolinone ring of pimozide is either maintained or modified, in order to obtain further structure–activity relationship information for this class of STAT5 inhibitors. Two compounds of the series showed potent cytotoxic activity against BCR-ABL-positive and pSTAT5-overexpressing K562 cells and were able to markedly decrease the levels of phosphorylated STAT5.",
author = "Stefania Grimaudo and Maria Meli and Pipitone, {Rosaria Maria} and Daniele Simoni and Antonio Cascio and Riccardo Rondanin and Daniele Simoni and Romeo Romagnoli and Martina Maccesi",
year = "2017",
language = "English",
volume = "12",
pages = "1183--1190",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Effects of Pimozide Derivatives on pSTAT5 in K562 Cells

AU - Grimaudo, Stefania

AU - Meli, Maria

AU - Pipitone, Rosaria Maria

AU - Simoni, Daniele

AU - Cascio, Antonio

AU - Rondanin, Riccardo

AU - Simoni, Daniele

AU - Romagnoli, Romeo

AU - Maccesi, Martina

PY - 2017

Y1 - 2017

N2 - STAT5 is a transcription factor, a member of the STAT family of signaling proteins. STAT5 is involved in many types of cancer, including chronic myelogenous leukemia (CML), in which this protein is found constitutively activated as a consequence of BCR-ABL expression. The neuroleptic drug pimozide was recently reported to act as an inhibitor of STAT5 phosphorylation and is capable of inducing apoptosis in CML cells in vitro. Our research group has synthesized simple derivatives of pimozide with cytotoxic activity and that are able to decrease the levels of phosphorylated STAT5. In this work we continued the search for novel STAT5 inhibitors, synthesizing compounds in which the benzoimidazolinone ring of pimozide is either maintained or modified, in order to obtain further structure–activity relationship information for this class of STAT5 inhibitors. Two compounds of the series showed potent cytotoxic activity against BCR-ABL-positive and pSTAT5-overexpressing K562 cells and were able to markedly decrease the levels of phosphorylated STAT5.

AB - STAT5 is a transcription factor, a member of the STAT family of signaling proteins. STAT5 is involved in many types of cancer, including chronic myelogenous leukemia (CML), in which this protein is found constitutively activated as a consequence of BCR-ABL expression. The neuroleptic drug pimozide was recently reported to act as an inhibitor of STAT5 phosphorylation and is capable of inducing apoptosis in CML cells in vitro. Our research group has synthesized simple derivatives of pimozide with cytotoxic activity and that are able to decrease the levels of phosphorylated STAT5. In this work we continued the search for novel STAT5 inhibitors, synthesizing compounds in which the benzoimidazolinone ring of pimozide is either maintained or modified, in order to obtain further structure–activity relationship information for this class of STAT5 inhibitors. Two compounds of the series showed potent cytotoxic activity against BCR-ABL-positive and pSTAT5-overexpressing K562 cells and were able to markedly decrease the levels of phosphorylated STAT5.

UR - http://hdl.handle.net/10447/290599

UR - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187

M3 - Article

VL - 12

SP - 1183

EP - 1190

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

ER -